BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+86.3%
5Y CAGR+127.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+86.3%/yr
Annual compound
5Y CAGR
+127.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
60.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$502.08M+126.3%
2024$221.90M+2285.3%
2023$9.30M-88.0%
2022$77.65M+11.4%
2021$69.72M+745.1%
2020$8.25M-79.7%
2019$40.56M-
2018$0.00-
2017$0.00-